Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

Center, 2012, International variation in prostate cancer incidence and mortality rates, Eur Urol, 61, 1079, 10.1016/j.eururo.2012.02.054

Roobol, 2013, Screening for prostate cancer: results of the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer, Eur Urol, 64, 530, 10.1016/j.eururo.2013.05.030

Heijnsdijk, 2012, Quality-of-life effects of prostate-specific antigen screening, N Engl J Med, 367, 595, 10.1056/NEJMoa1201637

Holmstrom, 2009, Prostate specific antigen for early detection of prostate cancer: longitudinal study, BMJ, 339, b3537, 10.1136/bmj.b3537

Resnick, 2013, Long-term functional outcomes after treatment for localized prostate cancer, N Engl J Med, 368, 436, 10.1056/NEJMoa1209978

Thompson, 2005, Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower, JAMA, 294, 66, 10.1001/jama.294.1.66

Loeb, 2014, Overdiagnosis and overtreatment of prostate cancer, Eur Urol, 65, 1046, 10.1016/j.eururo.2013.12.062

Bul, 2012, Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer, BJU Int, 110, 1672, 10.1111/j.1464-410X.2012.11434.x

Cooperberg, 2011, Outcomes of active surveillance for men with intermediate-risk prostate cancer, J Clin Oncol, 29, 228, 10.1200/JCO.2010.31.4252

Klotz, 2013, Prostate cancer overdiagnosis and overtreatment, Curr Opin Endocrinol Diabetes Obes, 20, 204, 10.1097/MED.0b013e328360332a

Moyer, 2012, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 120, 10.7326/0003-4819-157-2-201207170-00459

Heidenreich, 2013, Early detection of prostate cancer: European Association of Urology recommendation, Eur Urol, 64, 347, 10.1016/j.eururo.2013.06.051

Dahabreh, 2012, Active surveillance in men with localized prostate cancer: a systematic review, Ann Intern Med, 156, 582, 10.7326/0003-4819-156-8-201204170-00009

Lecornet, 2012, The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation, J Urol, 188, 974, 10.1016/j.juro.2012.04.104

Taira, 2013, Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance, Am J Clin Oncol, 36, 116, 10.1097/COC.0b013e31823fe639

Kobus, 2012, Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T, Radiology, 265, 457, 10.1148/radiol.12111744

Selnaes, 2012, Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology, Invest Radiol, 47, 624, 10.1097/RLI.0b013e318263f0fd

Turkbey, 2010, Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475

Ahmed, 2009, Is it time to consider a role for MRI before prostate biopsy?, Nat Rev Clin Oncol, 6, 197, 10.1038/nrclinonc.2009.18

Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004

Rastinehad, 2014, Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy, J Urol, 191, 1749, 10.1016/j.juro.2013.12.007

Haffner, 2011, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 108, E171, 10.1111/j.1464-410X.2011.10112.x

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Kuru, 2013, Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate, BJU Int, 112, 1080, 10.1111/bju.12259

Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044

Moore, 2013, Standards of Reporting for MRI-targeted Biopsy Studies (START) of the prostate: recommendations from an International Working Group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030

Wolters, 2011, A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial, J Urol, 185, 121, 10.1016/j.juro.2010.08.082

Mercaldo, 2007, Confidence intervals for predictive values with an emphasis to case-control studies, Stat Med, 26, 2170, 10.1002/sim.2677

Stamey, 2010, Bayesian interval estimation for predictive values from case-control studies, Commun Stat, 39, 101, 10.1080/03610910903312219

Enøe, 2000, Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown, Prev Vet Med, 45, 61, 10.1016/S0167-5877(00)00117-3

Hui, 1980, Estimating the error rates of diagnostic tests, Biometrics, 36, 167, 10.2307/2530508

Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520, 10.1016/j.juro.2009.10.022

Kasivisvanathan, 2013, Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer, J Urol, 189, 860, 10.1016/j.juro.2012.10.009

Van de Ven, 2013, MRI/US-guided biopsy—a viable alternative to TRUS-guidance, Nat Rev Urol, 10, 559, 10.1038/nrurol.2013.179

Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059

van de Ven, 2013, Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies, Eur Radiol, 23, 1401, 10.1007/s00330-012-2701-1

de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JPC. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012

Schroder, 2012, Prostate-cancer mortality at 11 years of follow-up, N Engl J Med, 366, 981, 10.1056/NEJMoa1113135

Schröder, 2012, Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC), Eur Urol, 62, 745, 10.1016/j.eururo.2012.05.068